[{"id":"7f44dec8-1a44-4b9d-ac82-d895aae03fb0","acronym":"","url":"https://clinicaltrials.gov/study/NCT02144051","created_at":"2021-01-18T09:57:38.493Z","updated_at":"2024-07-02T16:37:30.569Z","phase":"Phase 1","brief_title":"Phase I Open Label Dose Escalation Study to Investigate the Safety \u0026 Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors","source_id_and_acronym":"NCT02144051","lead_sponsor":"AstraZeneca","biomarkers":" AR","pipe":"","alterations":" ","tags":["AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IONIS-AR-2.5Rx"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 05/01/2014","start_date":" 05/01/2014","primary_txt":" Primary completion: 03/01/2016","primary_completion_date":" 03/01/2016","study_txt":" Completion: 03/01/2016","study_completion_date":" 03/01/2016","last_update_posted":"2016-07-14"}]